Mechanisms of cough in Mycobacterium tuberculosis transmission

咳嗽在结核分枝杆菌传播中的机制

基本信息

  • 批准号:
    10185506
  • 负责人:
  • 金额:
    $ 70.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-08 至 2026-02-28
  • 项目状态:
    未结题

项目摘要

Project Abstract The success of any bacterial pathogen ultimately depends on its ability to multiply and transmit to new hosts. Mycobacterium tuberculosis (Mtb), the causative agent of the human disease tuberculosis and one of the most successful pathogens in human history, likely also employs sophisticated means to spread from one person to the next, including mediating caseation, tissue destruction, and airborne transmission. Yet, despite the toll Mtb has taken on world health, the molecular mechanisms responsible for Mtb transmission remain elusive. A major symptom of active tuberculosis is cough, and cough is a major mechanism of transmission. Although cough is a major route of aerosolization and transmission of Mtb, very little is known about the factors that produce cough during infection. Furthermore, epidemiologic studies have demonstrated that Mtb strains representing specific lineages are more prevalent in humans but whether differences in prevalence are due to differences in bacterial transmissibility and associated factors such as cough induction and aerosolization of bacteria is unknown. Thus, there is an urgent need to better characterize the transmission dynamics of Mtb and the relationship of cough to transmission. Because nociceptive neurons mediate cough, and some bacteria including mycobacteria secrete complex molecules targeting neurons, we hypothesized that Mtb produces molecules to trigger nociceptive neurons to activate the cough response, thereby facilitating transmission. We discovered and characterized the activity of one such molecule, sulfolipid-1, and recently identified a second molecule produced by virulent mycobacteria. In the proposed research we will (1) Identify and study the sulfolid-1 receptor in neurons and experimental animals, (2) Characterize the activity of the second nociceptive molecule in neurons and experimental animals, and determine how its activity combines with that of sulfolipid-1 (3) Develop and use a sophisticated Mtb transmission system to measure transmission, cough and aerosolized particles safely and quantitatively and use the system to compare the transmissibility of a variety of Mtb mutants lacking cough-inducing molecules. The proposed work is expected to identify novel factors associated with nociceptive neuron activation, cough and mycobacterial transmission.
项目摘要 任何细菌病原体的成功最终取决于其繁殖和传播给新宿主的能力。 结核分枝杆菌(Mtb),人类疾病结核病的病原体,也是最常见的 人类历史上成功的病原体,很可能也使用复杂的手段从一个人传播到 下一步,包括调解干酪化、组织破坏和空中传播。然而,尽管有Mtb的死亡人数 虽然已经对世界健康产生了影响,但导致结核分枝杆菌传播的分子机制仍然难以捉摸。一个 活动性肺结核的主要症状是咳嗽,而咳嗽是主要的传播机制。虽然 咳嗽是结核分枝杆菌雾化和传播的主要途径,目前对其影响因素知之甚少。 在感染期间产生咳嗽。此外,流行病学研究表明,结核分枝杆菌菌株 代表特定血统的基因在人类中更为普遍,但患病率的差异是否源于 细菌传播性及其相关因素如咳嗽和气雾化的差异 细菌是未知的。因此,迫切需要更好地表征结核分枝杆菌的传播动力学 以及咳嗽与传播的关系。因为伤害性神经元介导咳嗽,以及一些细菌 包括分枝杆菌分泌的针对神经元的复杂分子,我们假设结核分枝杆菌产生 触发伤害性神经元的分子,从而激活咳嗽反应,从而促进传递。我们 发现并表征了一种这样的分子的活性,硫脂-1,最近发现了第二种 由强毒分枝杆菌产生的分子。在拟议的研究中,我们将(1)确定和研究 神经元和实验动物中的Sulfolid-1受体,(2)表征第二种伤害性感受器的活性 分子,并确定其活性如何与Sulfolipid-1结合 (3)开发和使用复杂的结核分枝杆菌传播系统来测量传播、咳嗽和雾化 并利用该系统对多种结核分枝杆菌的传播率进行比较 缺乏咳嗽诱导分子的突变体。这项拟议的工作有望确定相关的新因素 具有伤害性神经元激活、咳嗽和分枝杆菌传播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL SHILOH其他文献

MICHAEL SHILOH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL SHILOH', 18)}}的其他基金

Mechanisms of cough in Mycobacterium tuberculosis transmission
咳嗽在结核分枝杆菌传播中的机制
  • 批准号:
    10368154
  • 财政年份:
    2021
  • 资助金额:
    $ 70.77万
  • 项目类别:
Project 3: Mechanisms of cough in M. tuberculosis transmission
项目3:咳嗽在结核分枝杆菌传播中的机制
  • 批准号:
    10404532
  • 财政年份:
    2021
  • 资助金额:
    $ 70.77万
  • 项目类别:
Mechanisms of cough in Mycobacterium tuberculosis transmission
咳嗽在结核分枝杆菌传播中的机制
  • 批准号:
    10578845
  • 财政年份:
    2021
  • 资助金额:
    $ 70.77万
  • 项目类别:
Project 3: Mechanisms of cough in M. tuberculosis transmission
项目3:咳嗽在结核分枝杆菌传播中的机制
  • 批准号:
    10190651
  • 财政年份:
    2021
  • 资助金额:
    $ 70.77万
  • 项目类别:
Project 3: Mechanisms of cough in M. tuberculosis transmission
项目3:咳嗽在结核分枝杆菌传播中的机制
  • 批准号:
    10610926
  • 财政年份:
    2021
  • 资助金额:
    $ 70.77万
  • 项目类别:
RP4: Harnessing autophagy to treat tuberculosis
RP4:利用自噬治疗结核病
  • 批准号:
    10573263
  • 财政年份:
    2019
  • 资助金额:
    $ 70.77万
  • 项目类别:
RP4: Harnessing autophagy to treat tuberculosis
RP4:利用自噬治疗结核病
  • 批准号:
    10364726
  • 财政年份:
    2019
  • 资助金额:
    $ 70.77万
  • 项目类别:
Human airway microfold cells in mucosal immunity to bacterial pathogens
人气道微褶皱细胞对细菌病原体的粘膜免疫
  • 批准号:
    9170079
  • 财政年份:
    2016
  • 资助金额:
    $ 70.77万
  • 项目类别:
Identification of novel M. tuberculosis secreted effector proteins
新型结核分枝杆菌分泌效应蛋白的鉴定
  • 批准号:
    8796158
  • 财政年份:
    2014
  • 资助金额:
    $ 70.77万
  • 项目类别:
Identification of novel M. tuberculosis secreted effector proteins
新型结核分枝杆菌分泌效应蛋白的鉴定
  • 批准号:
    8682011
  • 财政年份:
    2014
  • 资助金额:
    $ 70.77万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 70.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了